Wellgistics Health has issued convertible promissory notes due May 27, 2027, with zero percent interest and a 20% original issue discount under a securities purchase agreement. The notes are convertible to common stock subject to a 19.99% exchange cap, representing a financing activity that dilutes existing shareholders pending required stockholder approval.